>
DB BiotechDB Biotech
DB Biotech 成立于2006年,在開發(fā)用于研究和常規(guī)臨床診斷的高質(zhì)量抗體方面贏得了國際聲譽(yù)。DB Biotech的目標(biāo)是每天為抗體的開發(fā)和應(yīng)用建立新的黃金標(biāo)準(zhǔn),從無背景的蛋白質(zhì)印跡到特殊的定量診斷,以及用于疾病治療目的的人源化抗體的潛在應(yīng)用。
DB Biotech is focused on the design and production of high quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DBB scientific team over a period of 20 years. DB Biotech monospecific clonal antibodies are uniquely characterized by exceptional specificity, affinity and avidity.
The DB Biotech in-vitro cloning technology enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes only one single linear epitope on the antigen molecule, making a DB Biotech antibody comparable in quality to its monoclonal analogue.
產(chǎn)品列表:
No. |
品牌 |
貨號 |
名稱 |
規(guī)格 |
1 |
DB Biotech |
DB 126-0.1 |
AKT |
100 ul |
2 |
DB Biotech |
DB 208-0.1 |
AMACR |
100 ul |
3 |
DB Biotech |
DB 147-0.1 |
Actin alpha |
100 ul |
4 |
DB Biotech |
DB 001-IHC-0.1 |
Actin, Smooth Muscle |
100 ul |
5 |
DB Biotech |
DB 123-0.1 |
BAX |
100 ul |
6 |
DB Biotech |
DB 132-0.1 |
BCL-2 |
100 ul |
7 |
DB Biotech |
DB 186-0.1 |
C-FOS |
100 ul |
8 |
DB Biotech |
DB 018-0.1 |
C1QTNF5 |
100 ul |
9 |
DB Biotech |
DB 106-0.1 |
C3d complement |
100 ul |
10 |
DB Biotech |
DB 030-0.1 |
CD10 |
100 ul |
11 |
DB Biotech |
DB 062-0.1 |
CD117 |
100 ul |
12 |
DB Biotech |
DB 211-0.1 |
CD15 |
100 ul |
13 |
DB Biotech |
DB 045-0.1 |
CD163 |
100 ul |
14 |
DB Biotech |
DB 071-0.1 |
CD1a |
100 ul |
15 |
DB Biotech |
DB 041-0.1 |
CD20 |
100 ul |